Related by context. All words. (Click for frequent words.) 71 cisplatin 71 epirubicin 71 mycophenolate mofetil 71 etoposide 70 idarubicin 70 5FU 70 adriamycin 70 carboplatin paclitaxel 69 gemcitabine 69 fluorouracil 69 docetaxel 68 trastuzumab 68 5 fluorouracil 68 leucovorin 68 mitomycin 67 chemotherapy regimens 67 dacarbazine 67 neoadjuvant chemotherapy 67 #mg/m# [001] 67 gemcitabine chemotherapy 67 carboplatin 67 cytarabine 67 rituximab 67 daunorubicin 67 Fludara 67 doxorubicin cyclophosphamide 66 interferon alfa 2a 66 Cytoxan 66 melphalan 66 decitabine 66 nab paclitaxel 66 paclitaxel 66 methotrexate 66 chemotherapeutic agents 66 CHOP chemotherapy 66 chemotherapy regimen 66 docetaxel chemotherapy 65 mitoxantrone 65 sorafenib Nexavar 65 FOLFOX 65 chemoradiotherapy 65 azathioprine 65 FOLFIRI 65 cytotoxic chemotherapy 65 chemoradiation 65 chemotherapeutic regimens 65 pegylated liposomal doxorubicin 65 5 FU 65 alkylating agent 65 dexamethasone 65 temozolomide 65 topotecan 64 interferon alfa 2b 64 gemcitabine Gemzar 64 doxorubicin 64 NRTIs 64 chemotherapies 64 vinorelbine 64 5 FU leucovorin 64 cisplatin gemcitabine 64 5 Fluorouracil 64 dose dexamethasone 64 intravenous bisphosphonates 64 interferon alfa 64 dose cytarabine 64 dexamethasone Decadron 64 pemetrexed 64 bevacizumab 64 docetaxel Taxotere 63 paclitaxel Taxol 63 chemotherapy gemcitabine 63 fludarabine 63 bevacizumab Avastin ® 63 ritonavir boosted 63 standard chemotherapy regimen 63 Irinotecan 63 heavily pretreated patients 63 trabectedin 63 fulvestrant 63 taxane chemotherapy 63 Cisplatin 63 bortezomib 63 saline placebo 63 Peg IFN 63 pamidronate 63 docetaxel Taxotere ® 63 adjuvant therapy 63 androgen deprivation 63 estramustine 63 cyclophosphamide methotrexate 63 erlotinib Tarceva ® 63 erlotinib 63 bleomycin 63 imatinib 63 DMARDs 63 TAXOTERE R 63 Doxil ® 63 cisplatin chemotherapy 63 piperacillin tazobactam 63 pegylated interferon alfa 2a 63 neoadjuvant 63 pegylated interferon alfa 63 EBRT 63 mycophenolate mofetil MMF 63 pomalidomide 63 standard chemotherapy regimens 63 FOLFOX4 63 peginterferon alfa 2b 63 flutamide 62 DOXIL 62 Taxotere R 62 chemotherapeutic agent 62 plus ribavirin 62 trans retinoic acid 62 cidofovir 62 Taxotere chemotherapy 62 azacitidine 62 capecitabine 62 intravesical 62 irinotecan 62 temsirolimus 62 alkylating agents 62 pyrazinamide 62 paclitaxel Taxol R 62 gemcitabine carboplatin 62 6 mercaptopurine 62 xenograft models 62 bevacizumab Avastin 62 cetuximab 62 mg m² 62 hepatic metastases 62 ribavirin RBV 62 oxaliplatin 62 TACE 62 melphalan prednisone 62 mapatumumab 62 external beam radiotherapy 62 #mg/m# [002] 62 chemotherapeutic drug 62 peginterferon 61 Adriamycin 61 trastuzumab Herceptin R 61 Carboplatin 61 telaprevir dosed 61 Cyclophosphamide 61 gemcitabine cisplatin 61 mg/m2 61 danazol 61 antithymocyte globulin 61 alfa 2a 61 busulfan 61 overlapping toxicities 61 trans retinoic acid ATRA 61 mitomycin C 61 corticosteroids 61 taxanes 61 immunosuppressive agents 61 adalimumab 61 relapsed ovarian cancer 61 trastuzumab Herceptin ® 61 chlorambucil 61 paclitaxel chemotherapy 61 vincristine 61 imatinib Gleevec 61 oral clodronate 61 GnRH agonists 61 5-FU/LV 61 lenalidomide dexamethasone 61 temozolomide TMZ 61 pegylated interferon 61 neoadjuvant therapy 61 Taxotere ® 61 fluoropyrimidine 61 cytotoxic agents 61 metastatic renal cell carcinoma 61 docetaxel Taxotere R 61 caspofungin 61 paclitaxel Taxol ® 61 DMARDS 61 radiochemotherapy 61 abacavir lamivudine 61 Platinol ® 61 folinic acid 61 PREZISTA r 61 fluvastatin 61 mcg kg 61 lapatinib Tykerb 61 Gemcitabine 61 FUSILEV enhances 61 peginterferon alpha 2a 61 hormonal therapy 61 bendamustine 61 Telintra 61 sorafenib Nexavar ® 60 postoperative chemotherapy 60 anti leukemic 60 DMARD 60 APTIVUS r 60 zoledronic acid 60 posaconazole 60 superficial bladder cancer 60 goserelin 60 ribavirin therapy 60 azacytidine 60 mTOR inhibitors 60 intravenous cyclophosphamide 60 cyclophosphamide doxorubicin vincristine 60 pegfilgrastim 60 platelet inhibitor 60 MGd 60 peg interferon 60 irinotecan chemotherapy 60 liposomal doxorubicin 60 pharmacologically active isomer 60 administered subcutaneously 60 exemestane 60 4mg/kg 60 low dose dexamethasone 60 chemotherapy cisplatin 60 ribavirin 60 octreotide LAR 60 sulfasalazine 60 interferon 60 cetuximab Erbitux ® 60 mg kg dose 60 fluorouracil leucovorin 60 zoledronate 60 tenofovir Viread 60 Pemetrexed 60 anthracycline taxane 60 cyclophosphamide Cytoxan 60 imatinib therapy 60 neurologic progression 60 Capecitabine 60 ABVD 60 nelfinavir 60 oblimersen 60 Taxol paclitaxel 60 recurrent GBM 60 mg/m2 administered 60 CA4P 60 pertuzumab 60 Chemophase 60 ixabepilone 60 alpha 2a 60 protease inhibitor PI 60 antiandrogen 60 methotrexate therapy 60 cytotoxic 60 medroxyprogesterone acetate 60 tyrosine kinase inhibitor 60 thalidomide Thalomid 60 paclitaxel carboplatin 60 NRTI 60 peginterferon alfa 2a 60 plus dexamethasone 60 chemotherapy docetaxel 60 raltegravir 59 plus prednisone 59 mg m 59 taxane therapy 59 sorafenib 59 cytarabine daunorubicin 59 dosage regimens 59 Pegasys ® 59 liposomal amphotericin B 59 idraparinux 59 remission induction 59 octreotide 59 YONDELIS 59 fosamprenavir 59 anthracyclines 59 3TC lamivudine Epivir 59 isoproterenol 59 biologic DMARD 59 Neoadjuvant 59 ELOXATIN 59 boosted protease inhibitor 59 Mitoxantrone 59 q8h 59 Pegasys peginterferon alfa 2a 59 nucleoside reverse transcriptase inhibitors 59 milatuzumab 59 rituximab Rituxan 59 locoregional recurrence 59 cisplatin carboplatin 59 dasatinib 59 luteinizing hormone releasing 59 bortezomib Velcade R 59 prednisone 59 corticosteroid therapy 59 androgen suppression 59 DAPT 59 immunomodulatory therapy 59 sunitinib 59 low dose cytarabine 59 infusional 5-FU/LV 59 dasatinib Sprycel ® 59 PREZISTA rtv 59 APTIVUS 59 BEACOPP 59 tamoxifen 59 darunavir ritonavir 59 hematologic toxicity 59 amrubicin 59 dasatinib Sprycel 59 epirubicin cyclophosphamide 59 irinotecan doxorubicin oxaliplatin paclitaxel 59 calcineurin inhibitors 59 nucleoside analogs 59 amphotericin B 59 lenalidomide 59 TNF inhibitor 59 mCi 59 deferoxamine 59 steroid dexamethasone 59 HER2 positive metastatic breast 59 mRCC 59 GnRH agonist 59 monotherapy 59 doxorubicin docetaxel 59 methylprednisolone 59 infliximab 59 tigecycline 59 imetelstat 59 Gemzar ® 59 Peginterferon 59 taxane 59 mitoxantrone chemotherapy 59 bicalutamide 59 TNF inhibitors 59 anastrozole 59 5 fluorouracil leucovorin 59 FOLPI 59 relapsed MM 59 ethambutol 59 adjuvant radiation 59 q#h 59 MYLOTARG 59 lopinavir r 59 epirubicin cisplatin 59 Paraplatin ® 58 chemotherapy 58 Copegus ribavirin 58 atazanavir 58 immunosuppressive regimen 58 peginterferon alfa 58 nucleoside analog 58 ibandronate 58 pegylated interferon alpha 58 doxorubicin HCl liposome injection 58 relapsed refractory 58 Combination therapy 58 Taxotere 58 Fludarabine 58 cabazitaxel 58 myeloablative 58 LHRH analogues 58 debulking surgery 58 intramuscularly 58 Doxil 58 amprenavir 58 mcg dose 58 Platinol ® cisplatin 58 partial remissions 58 clodronate 58 chemotherapeutics 58 fibrinolytic 58 chemotherapeutic 58 Trastuzumab 58 tumor shrinkage 58 sunitinib malate 58 Q2W 58 doxorubicin Adriamycin 58 uric acid lowering 58 zidovudine 58 LPV r 58 anti angiogenic agents 58 cyclophosphamide vincristine 58 nadolol 58 recurrent glioblastoma multiforme 58 dose cyclophosphamide 58 vinca alkaloid 58 subcutaneous SC 58 visilizumab 58 GP IIb IIIa inhibitors 58 imatinib Gleevec ® 58 anthracycline 58 eribulin 58 comparator arm 58 bacillus Calmette Guerin 58 VELCADE melphalan 58 immunosuppressant 58 Vincristine 58 EGFR TKI 58 Fludara ® 58 dose regimens 58 Lenalidomide 58 clopidogrel Plavix 58 LHRH agonist 58 metastatic RCC 58 corifollitropin alfa 58 ertapenem 58 vandetanib 58 LHRH agonists 58 5-fluorouracil/leucovorin 58 nucleoside analogue 58 TTF Therapy 58 arsenic trioxide 58 interferon ribavirin 58 Fluorouracil 58 chemo radiotherapy 58 Temozolomide 58 lenalidomide Revlimid R 58 CANCIDAS 58 Taxol ® 58 oxaliplatin Eloxatin 58 dosing regimens 58 lamivudine 58 clopidogrel 58 DOXIL ® 58 intravenous infusions 58 cilengitide 58 degarelix 58 fluconazole 58 DFMO 58 zoledronic acid Zometa 58 VICTRELIS 58 Adjuvant chemotherapy 58 tipranavir 58 dose cohorts 58 vinblastine 58 unfractionated heparin 58 etanercept 58 Platinol 58 sorafenib tablets 58 Zoledronic acid 58 WBRT 58 stavudine d4T 58 concurrent chemoradiation 58 Folfox 58 bortezomib Velcade 58 seliciclib 58 infusional 58 voriconazole 58 biochemical relapse 58 nonmyeloablative 57 heavily pretreated 57 alpha interferons 57 abciximab 57 anthracycline chemotherapy 57 Ribavirin 57 pazopanib 57 erythropoietic 57 plus prednisone prednisolone 57 aspirin heparin 57 continuous intravenous infusion 57 XELOX 57 gemcitabine Gemzar ® 57 FluCAM 57 androgen ablation 57 bevacizumab Avastin R 57 protease inhibitor 57 temozolomide Temodar 57 VIDAZA 57 rifampicin 57 Bevacizumab 57 glucocorticoids 57 methotrexate MTX 57 injected subcutaneously 57 pegylated interferon alfa 2b 57 salmeterol fluticasone 57 Bezielle 57 nucleoside analogues 57 refractory multiple myeloma 57 chemoradiation therapy 57 cyclophosphamide doxorubicin 57 dexamethasone VAD 57 tanespimycin 57 mg/m2/day 57 CsA 57 FOLFOX chemotherapy 57 bendamustine ifosfamide 57 PEGylated anti 57 Pegylated Interferon 57 lapatinib 57 CoFactor 57 neoadjuvant treatment 57 administered orally 57 enzastaurin 57 rifampin 57 cytoreduction 57 Navelbine 57 ceftriaxone 57 CIMZIA TM 57 metastatic GIST 57 PegIFN 57 corticosteroid dexamethasone 57 mg BID 57 paclitaxel cisplatin 57 gefitinib Iressa 57 PegIFN RBV 57 enfuvirtide 57 irbesartan 57 regimens 57 chemotherapeutic drugs 57 fludarabine cyclophosphamide 57 surgical debulking 57 Pegasys plus Copegus 57 receiving VICTRELIS 57 Etoposide 57 tiotropium bromide 57 ara C 57 moxifloxacin 57 certolizumab 57 quinolone 57 allogeneic SCT 57 vinca alkaloids 57 Erlotinib 57 potentially hepatotoxic 57 Velcade bortezomib 57 dose melphalan 57 disease modifying antirheumatic 57 intravenous bolus 57 colorectal liver metastases 57 IFN alpha 57 thalidomide dexamethasone 57 myelosuppressive 57 DMARD therapy 57 AZT zidovudine Retrovir 57 chemoembolization 57 ® lenalidomide 57 granisetron 57 anti androgen 57 zalutumumab 57 mg QD 57 neostigmine 57 ganciclovir 57 FOLFOX6 57 mutated KRAS 57 systemic corticosteroids 57 efavirenz Sustiva 57 Imprime PGG 57 Docetaxel 57 active comparator 57 IV bolus 57 tenecteplase 57 cyclophosphamide chemotherapy 57 G CSF 57 mycophenolate 57 indinavir 57 Herceptin trastuzumab 57 8mg/kg 57 tumor regression 57 mg subcutaneously 57 thrombolytic agents 57 complete remissions 57 intradermal injection 57 captopril 57 PegIntron 57 biologic therapy 57 VNP#M 57 nevirapine Viramune 57 Flu Cy 57 mcg albinterferon alfa 2b 57 arsenic trioxide ATO 57 palifermin 57 azoles 57 tumor xenograft models 57 beclomethasone dipropionate 57 steroid prednisone 57 microtubule targeting 57 Melphalan 57 placebo dexamethasone 57 antimetabolite 57 anthracycline therapy 57 intravesical instillation 57 galiximab 57 trimethoprim sulfamethoxazole 57 bupivacaine 57 sunitinib Sutent ® 57 antitumor activity 57 preoperative chemotherapy 57 epoetin alfa 57 sirolimus 57 nucleoside reverse transcriptase inhibitor 56 adjuvant tamoxifen 56 EFAPROXYN 56 triamcinolone 56 dosed orally 56 intramuscular 56 mg/m2 dose 56 adjuvant chemotherapy 56 vorinostat 56 TNF antagonist 56 rindopepimut 56 sulphonylurea 56 myelosuppression 56 intravenously administered 56 prednisone prednisolone 56 refractory NSCLC 56 ifosfamide 56 tocilizumab 56 teriparatide 56 LHRH 56 immunosuppressives 56 letrozole Femara 56 taxol 56 capecitabine Xeloda 56 mesalamine 56 IV bisphosphonates 56 β blockers 56 indolent NHL 56 GEMZAR 56 anakinra 56 paclitaxel poliglumex 56 xanthine oxidase inhibitor 56 lanreotide 56 VIRAMUNE 56 peg IFN 56 erlotinib Tarceva 56 Bortezomib 56 leukemia AML 56 FASLODEX 56 reteplase 56 microwave hyperthermia 56 risedronate 56 Cremophor 56 adrenal suppression 56 plasma uric acid 56 adalimumab Humira 56 cetuximab Erbitux R 56 tinidazole 56 tamoxifen Nolvadex ® 56 alefacept 56 Faslodex 56 olmesartan 56 refractory chronic lymphocytic 56 adefovir 56 potent CYP#A# inhibitors 56 amoxicillin clavulanate 56 immunosuppressive 56 epoprostenol 56 TORISEL 56 Ceplene/IL-2 56 immunomodulator 56 pCR 56 #mg/kg [002] 56 Interferon alpha 56 median PFS 56 induce remission 56 Neupogen ® 56 myopathy rhabdomyolysis 56 Methotrexate 56 lopinavir 56 Cloretazine 56 Telmisartan 56 leukemia CLL 56 bone metastasis 56 dose colchicine 56 Aptivus ® 56 omega interferon 56 androgen deprivation therapy 56 antiarrhythmic drugs 56 Isoniazid 56 IMGN# 56 dexrazoxane 56 iodixanol 56 radiotherapy RT 56 imipenem 56 tamoxifen therapy 56 rhEPO 56 miconazole 56 liposomal formulation 56 interferon alpha 56 forodesine 56 previously untreated follicular 56 rHuEPO 56 severe neutropenia 56 anthracyclines taxanes 56 metastatic CRC 56 indomethacin 56 fallopian tube carcinoma 56 tirofiban 56 N acetylcysteine 56 zidovudine lamivudine 56 mCRC patients 56 pyridostigmine 56 thromboembolic events 56 oral Xeloda 56 infliximab monotherapy 56 eptifibatide 56 IFN alfa 56 prostate cancer HRPC 56 entecavir 56 Paraplatin ® carboplatin 56 stavudine 56 pegylated interferons 56 tamsulosin 56 fluticasone 56 cell lymphoma CTCL 56 chemotherapeutic regimen 56 refractory CLL 56 LEXIVA r 56 budesonide 56 verteporfin 56 lamivudine 3TC 56 HGS ETR2 56 pimecrolimus 56 Leucovorin 56 Tarceva TM 56 axitinib 56 antiandrogens 56 tenofovir emtricitabine 56 Xeloda ® 56 d4T stavudine Zerit 56 transurethral resection 56 zidovudine AZT 56 hydroxymethyl coenzyme 56 HBeAg positive patients 56 dosing schedules 56 interferon therapy 56 INTELENCE 56 efalizumab 56 ISTODAX 56 Pegylated interferon 56 thiazide diuretic 56 nonsteroidal 56 fallopian tube cancers 56 vancomycin 56 SCCHN 56 acute GvHD 56 anastrazole 56 anti TNF 56 sotalol 56 conventional DMARDs 56 antiemetics 56 Camptosar ® 56 protease inhibitors 56 efavirenz EFV 56 mycophenolic acid 56 suppressive therapy 56 peginterferon alfa 2a #KD 56 hypercalcemia 56 amodiaquine 56 trastuzumab Herceptin 56 dose corticosteroids 56 TNF antagonists 56 isoniazid 56 thymalfasin 56 HRPC 56 vasodilators 56 IIIa inhibitor 56 allogeneic stem cell 56 leflunomide 56 orally bioavailable 56 mg dose 56 cis retinoic acid 56 Torisel 56 dacarbazine DTIC 56 intravenous dosing 56 basiliximab 56 peginterferon alfa 2a Pegasys 56 bisphosphonate therapy 56 Pegasys R 56 Targretin 56 NMIBC 56 mitoxantrone plus 56 TELINTRA 56 aminoglycoside 56 Peginterferon alfa 2b 56 relapsed myeloma 56 angiotensin converting enzyme inhibitors 56 K ras mutations 56 HSCT 55 celecoxib 55 tyrosine kinase inhibitors 55 subcutaneous enoxaparin 55 Vidaza azacitidine 55 nicardipine 55 SCIg 55 Allovectin 7 ® 55 sulindac 55 3TC 55 sorafenib Nexavar R 55 HGS# 55 cytoreductive surgery 55 Hycamtin ® 55 viral kinetics 55 iniparib 55 Interferon 55 ritonavir 55 ketorolac 55 weekly subcutaneous injections 55 basal cell carcinoma BCC 55 hydroxychloroquine 55 corticosteroid 55 achieved ACR# 55 Femara letrozole 55 μg dose 55 Cyclosporine 55 insulin glargine 55 oral antidiabetic 55 meropenem 55 BCG refractory 55 Sandostatin LAR 55 fibrinolysis 55 interferon IFN 55 nitazoxanide 55 MAGE A3 ASCI 55 ZOLINZA 55 Jevtana 55 EGFR expressing 55 resistant ovarian cancer 55 pegylated interferon peg IFN 55 microtubule inhibitor 55 Temsirolimus 55 angiotensin receptor blocker ARB 55 VAPRISOL 55 IFN beta 55 lenalidomide Revlimid ® 55 autologous stem cell 55 anthracycline containing 55 beta agonists 55 bolus injection 55 raloxifene Evista 55 relapsing multiple sclerosis 55 rhTSH 55 intravenous immunoglobulin 55 tiotropium 55 #mg BID [003] 55 leukotriene receptor antagonist 55 paclitaxel eluting stents 55 CLL cells 55 strontium ranelate 55 Xanafide 55 glycoprotein IIb IIIa inhibitors 55 sulfonylurea 55 administered intravenously 55 immunosuppression 55 ELACYT 55 glargine 55 lispro 55 NNRTIs 55 metformin sulfonylurea 55 thiazolidinedione 55 aromatase inhibitor 55 ALA PDT 55 Desferal 55 nanomolar 55 EGFR inhibitors 55 Sandostatin R 55 Taxotere docetaxel 55 cytotoxicity 55 unfractionated heparin UFH 55 #mg QD [002] 55 nilotinib 55 evaluating Xcytrin 55 lumbar spine BMD 55 esomeprazole 55 tenofovir DF 55 oral antifungal 55 adecatumumab 55 pegylated alpha interferon 55 TO AVOID PREGNANCY WHILE 55 coxibs 55 antiangiogenic therapy 55 pharmacodynamic profile 55 dimeglumine 55 abacavir Ziagen 55 gefitinib 55 cranial irradiation 55 Gemzar gemcitabine 55 ascending doses 55 Panzem R NCD 55 FIRMAGON 55 metastatic hormone refractory 55 refractory AML 55 Epirubicin 55 chemotherapy FOLFOX 55 cediranib 55 renal toxicity 55 virologic failure 55 Omacetaxine mepesuccinate 55 CCR5 antagonist 55 PREZISTA ritonavir 55 gemtuzumab ozogamicin 55 TYKERB 55 bolus dose 55 TKI therapy 55 intravesical therapy 55 cytotoxic therapy 55 intramuscular injections 55 antiresorptive 55 FOLFOX6 chemotherapy regimen 55 adjuvant radiotherapy 55 angiotensin converting enzyme inhibitor 55 chronic lymphocytic leukemia CLL 55 Azacitidine 55 relapsed refractory multiple myeloma 55 oral levofloxacin 55 antiangiogenic 55 Bevacizumab Avastin 55 hypomethylating agents 55 tretinoin 55 nephrotoxic 55 pegylated 55 titrated glipizide 55 TroVax ® 55 imatinib resistant 55 plus gemcitabine 55 receiving highly emetogenic 55 LMWH 55 evaluable patients 55 grade gliomas 55 plus methotrexate 55 dose clopidogrel 55 prophylactic antibiotics 55 platinum refractory 55 paricalcitol 55 Noxafil 55 OPAXIO 55 taxotere 55 aprepitant 55 complete cytogenetic 55 Mitomycin C 55 clotrimazole 55 KRAS mutations occur 55 rFVIIa 55 intermittent dosing 55 adefovir dipivoxil 55 Orally administered 55 receptor tyrosine kinase inhibitor 55 Anthracycline 55 systemic corticosteroid 55 darunavir r 55 oral rivaroxaban 55 EOquin TM 55 ug kg 55 tacrolimus 55 darunavir 55 plus 5-FU/LV 55 anti TNF alpha 55 capecitabine Xeloda R 55 cytogenetic responses 55 Seliciclib 55 Teriflunomide 55 mg kg 55 splenectomized patients 55 intravenous infusion 55 bezafibrate 55 Gleevec imatinib 55 terbutaline 55 systemic immunosuppressive 55 Neulasta ® 55 interferons 55 atazanavir ritonavir 55 elacytarabine 55 free survival PFS 55 cinacalcet 55 risedronate Actonel 55 amikacin 55 subcutaneous injections 55 relapsed CLL 55 taxane resistant 55 celgosivir 55 pharmacokinetic interactions 55 glucose lowering 55 Hycamtin 55 immunomodulating 55 patients evaluable 55 renal dysfunction 55 ritonavir boosted lopinavir 55 VEGF inhibitors 55 ovarian carcinoma 55 sargramostim 55 antitumor effect 55 Imiquimod 55 clomipramine 55 PKC# 55 drug DMARD 54 mCi kg 54 Protelos 54 ß blockers 54 Elacytarabine 54 dacarbazine chemotherapy 54 EGFR tyrosine kinase inhibitors 54 PEGASYS ® 54 endometrial hyperplasia 54 febrile neutropenia 54 vincristine doxorubicin 54 intra arterial chemotherapy 54 cetuximab Erbitux 54 therapeutic regimens 54 bone marrow suppression 54 FEMALES SHOULD BE ADVISED 54 complete cytogenetic response 54 recurrent metastatic 54 HBeAg seroconversion